Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Protara Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- 0 vs. Q1 2023
- Shares held
- 5.14M
- −366.4K (−6.7%) vs. Q1 2023
- Total value
- $12.3M
- −$4.62M (−27.4%) vs. Q1 2023
- New holders
- 3
- 5 more added
- Sold out
- 3
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $6.44M | 1.54% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 772,584 | $1.85M | 0.04% | −20,974−2.6% | Reduced |
| Vanguard Group Inc | 427,612 | $1.02M | 0.00% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $500.0K | 0.02% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 199,671 | $477.2K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 188,664 | $450.9K | 0.16% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 119,730 | $271.8K | 0.21% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 83,600 | $200.0K | 0.00% | +24,694+41.9% | Added |
| Geode Capital Management, LLC | 83,420 | $199.4K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 64,000 | $153.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 36,238 | $86.6K | 0.00% | −854−2.3% | Reduced |
| Two Sigma Investments, LP | 34,745 | $83.0K | 0.00% | −1,000−2.8% | Reduced |
| Two Sigma Advisers, LP | 31,318 | $74.8K | 0.00% | −300−0.9% | Reduced |
| State Street Corp | 30,900 | $73.9K | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 29,051 | $69.4K | 0.00% | +11,715+67.6% | Added |
| Millennium Management LLC | 24,548 | $58.7K | 0.00% | −1,773−6.7% | Reduced |
| Northern Trust Corp | 20,587 | $49.2K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 18,864 | $45.1K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 18,752 | $44.8K | 0.00% | +1,918+11.4% | Added |
| Bank of New York Mellon Corp | 17,907 | $42.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,008 | $23.9K | 0.00% | −36,179−78.3% | Reduced |
| LPL Financial LLC | 10,000 | $23.9K | 0.00% | −25−0.2% | Reduced |
| Acadian Asset Management LLC | 6,314 | $15.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,420 | $8.00K | 0.00% | +3,320+3,320.0% | Added |
| Tower Research Capital LLC (TRC) | 2,211 | $5.28K | 0.00% | +2,211 | New |
| Wells Fargo & Company | 563 | $1.35K | 0.00% | +3+0.5% | Added |
| Advisor Group Holdings, Inc. | 100 | $239 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9 | $23 | 0.00% | +9 | New |
| Simplex Trading, LLC | 195 | $0 | 0.00% | +195 | New |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −290,051−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −58,364−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −971−100.0% | Sold out |